Jessica Keim-Malpass,1 Aubrey Doede,1 Shayna L Showalter2 1Department of Acute and Specialty Care, University of Virginia School of Nursing, Charlottesville, VA 22908, USA; 2Department of Surgery, University of Virginia School of Medicine, Charlottesville, VA 22908, USA Purpose: Functional health literacy is critical for patients’ functional understanding and management of disease including adherence to medications and treatment recommendations. The purpose of this study was to determine if there is a relationship between self-reported health literacy and 1) decision to take adjuvant endocrine therapy and 2) adherence to adjuvant endocrine therapy at 2 years among women with breast cancer.Methods: We initiated a prospective health l...
Adherence to adjuvant endocrine therapy (AET) for breast cancer is suboptimal. The purpose of this s...
This is the peer reviewed version of the following article: Brett, J., et. al. (2018). Factors Assoc...
<p>Background: Adjuvant endocrine therapy is recommended for women with oestrogen receptor-po...
Background: Assessing health literacy and patient activation at the beginning of care could facilita...
Background: Adjuvant endocrine therapy (AET) is highly efficacious, significantly reducing breast ca...
Thesis (Ph.D.)--University of Washington, 2015Estrogen receptor-positive (ER+) breast cancer is diag...
PURPOSE: Oral anti-cancer medications are increasingly common and endocrine therapies represent the ...
Adjuvant endocrine hormonal therapy (EHT) is highly effective and appropriate for nearly all breast ...
Introduction: Despite evidence of the efficacy of adjuvant endocrine therapy (AET) in reducing the r...
Introduction: Despite evidence of the efficacy of adjuvant endocrine therapy (AET) in reducing the r...
Jo Brett,1 Mary Boulton,1 Debbie Fenlon,2 Nick J Hulbert-Williams,3 Fiona M Walter,4 Peter Donnelly,...
Introduction: Adjuvant endocrine therapy improves recurrence-free and overall survival in primary br...
Introduction: Adjuvant endocrine therapy improves recurrence-free and overall survival in primary br...
Adjuvant endocrine therapy (AET) taken for a minimum of five years reduces the recurrence and mortal...
Purpose: To inform intervention development, we measured the modifiable determinants of endocrine th...
Adherence to adjuvant endocrine therapy (AET) for breast cancer is suboptimal. The purpose of this s...
This is the peer reviewed version of the following article: Brett, J., et. al. (2018). Factors Assoc...
<p>Background: Adjuvant endocrine therapy is recommended for women with oestrogen receptor-po...
Background: Assessing health literacy and patient activation at the beginning of care could facilita...
Background: Adjuvant endocrine therapy (AET) is highly efficacious, significantly reducing breast ca...
Thesis (Ph.D.)--University of Washington, 2015Estrogen receptor-positive (ER+) breast cancer is diag...
PURPOSE: Oral anti-cancer medications are increasingly common and endocrine therapies represent the ...
Adjuvant endocrine hormonal therapy (EHT) is highly effective and appropriate for nearly all breast ...
Introduction: Despite evidence of the efficacy of adjuvant endocrine therapy (AET) in reducing the r...
Introduction: Despite evidence of the efficacy of adjuvant endocrine therapy (AET) in reducing the r...
Jo Brett,1 Mary Boulton,1 Debbie Fenlon,2 Nick J Hulbert-Williams,3 Fiona M Walter,4 Peter Donnelly,...
Introduction: Adjuvant endocrine therapy improves recurrence-free and overall survival in primary br...
Introduction: Adjuvant endocrine therapy improves recurrence-free and overall survival in primary br...
Adjuvant endocrine therapy (AET) taken for a minimum of five years reduces the recurrence and mortal...
Purpose: To inform intervention development, we measured the modifiable determinants of endocrine th...
Adherence to adjuvant endocrine therapy (AET) for breast cancer is suboptimal. The purpose of this s...
This is the peer reviewed version of the following article: Brett, J., et. al. (2018). Factors Assoc...
<p>Background: Adjuvant endocrine therapy is recommended for women with oestrogen receptor-po...